The treatment of deep venous thrombosis, including the newer agents

Dis Mon. 2005 Feb-Mar;51(2-3):104-11. doi: 10.1016/j.disamonth.2005.03.004.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Fondaparinux
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Incidence
  • Polysaccharides / adverse effects
  • Polysaccharides / therapeutic use*
  • Pulmonary Embolism / drug therapy*
  • Pulmonary Embolism / mortality
  • Thrombocytopenia / chemically induced
  • Venous Thrombosis / complications
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / epidemiology
  • Warfarin / adverse effects
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Polysaccharides
  • Warfarin
  • Fondaparinux